Ventas, Inc.

The full register, from 13F filings

The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 913 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.

Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.

What a reader needs to know to read these numbers

• Ventas has an active loans-and-investments book, which is credit exposure and NOT sized as an equity holding here. As of 30 Jun 2026 (10-Q Note 6): secured loans receivable and investments, net, $436.4 million (up from $143.9 million at 31 Dec 2025, mainly due to a $300.0 million, six-year, interest-only senior secured Scion Term Loan originated June 2026 to Scion, an affiliate/parent-company group of tenant Kindred Healthcare); plus non-mortgage loans receivable, net, $20.7 million. None of these loans were found to carry an equity conversion feature, warrant, or option in the filing text searched; they are excluded from holdings entirely rather than sized as equity.
• Combined-balance trap: Ventas' equity-method investments in Atria Senior Living (34% interest) and Ardent Health (approx. 6.6% interest, this is the unconsolidated-operating-entity equity-method view, distinct from the public-market Ardent position sized separately in holdings) are both carried within a single 'Other assets' balance sheet line ($834,429 thousand at 30 Jun 2026), which also includes non-mortgage loans receivable and other corporate assets. No per-investee split is disclosed anywhere in the 10-Q or the FY2025 10-K, so Atria's carrying value is left null (per brief rule) and the combined balance is recorded here rather than assigned to either investee.
• Exhibit 21 (subsidiaries list) to the FY2025 10-K was checked and, consistent with the brief's own caution that the format varies by registrant, carries NO ownership-percentage column: it is a plain name/jurisdiction list of (overwhelmingly wholly owned) subsidiaries, so it added no additional equity-stake sizing beyond 10-Q Note 7.
• 'All other' unconsolidated real estate entities: 10-Q Note 7 discloses a residual bucket of parking-structure and other de minimis investments, ownership range 34.0%-37.5%, combined carrying value $570,000 at 30 Jun 2026. This is a combined balance covering multiple small, unnamed entities and is too immaterial and diffuse to size individually or include as its own holdings row; noted here and in unknowns rather than assigned to any single entity.
• Ventas Realty, Limited Partnership (VRLP) is Ventas' financing subsidiary and issuer/guarantor of registered senior notes; the 10-Q was searched for outside limited-partnership unitholders (the OP-unit register risk flagged in the research brief, per the Blackstone/Schwarzman defect) and no evidence of third-party VRLP unitholders converting into VTR common stock was found. VRLP appears to be a wholly owned financing vehicle, not an UPREIT structure with outside unitholders, so no register row was modelled with shares: null for this reason.
• Register self-gate, computed from this file exactly as specified (no rows are_aggregate or rolls_up_into; none needed, since this register is purely institutional 13F holders with no proxy officers/insiders group to de-duplicate): 11 rows, 300,179,574 shares, 58.52% of the 512,946,359 shares outstanding (28 Jul 2026). This is a few points above the brief's rough 25-45% (and even its 55% outer bound) guide range; checked for double-counting (no shared CIKs across rows, Geode and FMR/Fidelity are legally distinct filers, Capital Group's 4 CIKs individually verified with 2 holding zero) and for the T. Rowe Price / Cohen & Steers thousands-of-dollars VALUE bug (found and corrected on both). All 11 rows imply a per-share price of $88.48-$89.66, a tight cluster consistent with VTR's actual Q2 2026 close, which is the strongest available cross-check that no row is a units/thousands/pre-split error. The elevated total appears to reflect genuinely heavy institutional ownership of this REIT (the project's own Q1 2026 VTR 13F snapshot, data/registers/VTR.json, shows 913 total 13F filers reporting 497,180,992 shares combined, about 97% of shares outstanding at that time), not a data defect. Corroborated first-hand by the coordinator against an independent source: this project's own 13F-derived register (data/registers/VTR.json, period 31 Mar 2026, built by a separate pipeline from the bulk 13F data) reports total institutional ownership of 406,982,074 shares, 79.34% of the same denominator, and its top ELEVEN holders alone sum to 57.21%. The eleven rows in this file sum to 58.52%, essentially the same figure from a different quarter and a different pipeline, so the level is real rather than a double count or a units error.
• Register figures are Q2 2026 (period 2026-06-30) 13F-HR data, refreshed directly from each holder's own filing rather than taken from Ventas' own DEF 14A (filed 2026-04-01), whose beneficial-ownership table cites stale Schedule 13G data for its top holders (Vanguard as of 29 Dec 2023, BlackRock as of 31 Dec 2023, JPMorgan as of a Jan 2026 13G, State Street as of 31 Mar 2025). The proxy's Vanguard figure (63,988,891 sh, 13.5%) and BlackRock figure (41,935,325 sh, 8.8%) are both well below the fresh Q2 2026 13F figures used in this file, consistent with the brief's warning to prefer the fresh 13F over a stale 13G quoted in a proxy.